Position in NVO
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$758,314
+$91,963 QoQ
Shares Held
15,818
-12.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#589
of 1,348 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Abacus Wealth Partners, LLC holds $15,909,181 across 13 Drug Manufacturers - General names. NVO ranks #8 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,810 | $4,523,205 | |
| 2 | ABBV |
AbbVie Inc.
|
8,029 | $2,020,417 | |
| 3 | LLY |
ELI LILLY & Co
|
1,508 | $1,808,740 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,511 | $1,479,163 | |
| 5 | NVS |
Novartis AG
|
8,613 | $1,349,829 | |
| 6 | BIIB |
Biogen Inc.
|
4,808 | $1,038,816 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,107 | $771,558 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
15,818 | $758,314 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $758,314 | 15,818 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $666,351 | 18,132 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,356,715 | 26,665 | Shares | Sole | 2026-02-05 | |
| No filing history on record for this holder in this stock. | ||||||